Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.
Küsters-Vandevelde HV, Willemsen AE, Groenen PJ, Küsters B, Lammens M, Wesseling P, Djafarihamedani M, Rijntjes J, Delye H, Willemsen MA, van Herpen CM, Blokx WA.
Küsters-Vandevelde HV, et al. Among authors: kusters b.
Acta Neuropathol Commun. 2014 Apr 8;2:41. doi: 10.1186/2051-5960-2-41.
Acta Neuropathol Commun. 2014.
PMID: 24713450
Free PMC article.